Literature DB >> 12959717

Refractory sprue.

Andrea N Culliford1, Peter H R Green.   

Abstract

Celiac disease is a T cell-mediated disorder that results from intolerance to gluten. The major cause of failure to respond to a gluten-free diet is continuing gluten ingestion. In poorly responsive patients diagnosis of refractory sprue can be established after exclusion of a limited number of conditions. Refractory sprue may occur after an initial response to the diet or without evidence of preexisting celiac disease. The detection of aberrant, clonally expanded, intraepithelial lymphocytes has led to better definition and classification of patients with refractory sprue. Only a few series of patients with well-characterized refractory sprue have been reported in the literature. The prognosis is poor, though some patients respond to corticosteroids and immunosuppressive agents. The presence of an aberrant clonal intraepithelial T-cell population has led to the designation of refractory sprue as a cryptic intestinal T-cell lymphoma.

Entities:  

Mesh:

Year:  2003        PMID: 12959717     DOI: 10.1007/s11894-003-0049-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  48 in total

Review 1.  Fatal leukemia in interleukin-15 transgenic mice.

Authors:  T A Fehniger; K Suzuki; J B VanDeusen; M A Cooper; A G Freud; M A Caligiuri
Journal:  Blood Cells Mol Dis       Date:  2001 Jan-Feb       Impact factor: 3.039

2.  Proceedings: Collagenous basement membrane thickening in jejunal biopsies from patients with adult coeliac disease.

Authors:  R Bossart; K Henry; W F Doe; C C Booth
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

3.  Soy protein--another cause of the flat intestinal lesion.

Authors:  M E Ament; C E Rubin
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

4.  Push enteroscopy in celiac sprue and refractory sprue.

Authors:  C Cellier; E Cuillerier; N Patey-Mariaud de Serre; P Marteau; V Verkarre; J Brière; N Brousse; J P Barbier; J Schmitz; B Landi
Journal:  Gastrointest Endosc       Date:  1999-11       Impact factor: 9.427

5.  Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue.

Authors:  C Sategna-Guidetti; R Pulitanó; S Grosso; G Ferfoglia
Journal:  J Clin Gastroenterol       Date:  1993-09       Impact factor: 3.062

6.  Intestinal ulceration and malabsorption syndromes.

Authors:  A N Baer; T M Bayless; J H Yardley
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

7.  Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study.

Authors:  P J Wahab; J B Crusius; J W Meijer; J J Uil; C J Mulder
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

8.  Successful infliximab treatment for steroid-refractory celiac disease: a case report.

Authors:  Helen R Gillett; Ian D R Arnott; Margaret McIntyre; Simon Campbell; Anna Dahele; Matthew Priest; Robert Jackson; Subrata Ghosh
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

9.  Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery.

Authors:  Peter J Wahab; Jos W R Meijer; Chris J J Mulder
Journal:  Am J Clin Pathol       Date:  2002-09       Impact factor: 2.493

10.  Etiology of nonresponsive celiac disease: results of a systematic approach.

Authors:  Ahmad S Abdulkarim; Lawrence J Burgart; Jacalyn See; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  2 in total

1.  A rare case of enteropathy-associated T-cell lymphoma presenting as acute renal failure.

Authors:  Milena Bakrac; Branka Bonaci; Miodrag Krstic; Sanja Simic; Milica Colovic
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

2.  Adult autoimmune enteropathy: Mayo Clinic Rochester experience.

Authors:  Salma Akram; Joseph A Murray; Darrell S Pardi; Glenn L Alexander; John A Schaffner; Pierre A Russo; Susan C Abraham
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-01       Impact factor: 11.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.